Literature DB >> 29775995

Phosphorylation alters Bim-mediated Mcl-1 stabilization and priming.

Jason E Conage-Pough1,2, Lawrence H Boise2.   

Abstract

Mcl-1 is a highly labile protein, subject to extensive post-translational regulation. This distinguishes Mcl-1 from other antiapoptotic proteins and necessitates further study to better understand how interactions with proapoptotic Bcl-2 proteins affect its regulation. One such protein, Bim, is known to stabilize Mcl-1, and Bim phosphorylation has been associated with increased Mcl-1 binding. Consequently, we investigated the potential impact of Bim phosphorylation on Mcl-1 stability. We found that Bim stabilizes and primes Mcl-1 in RPCI-WM1 cells and is constitutively phosphorylated. Additionally, introduction of several phospho-mimetic and unphosphosphorylateable Bim mutations resulted in altered Mcl-1 stability and distinct Bim binding to antiapoptotic proteins. These findings suggest Bim phosphorylation not only regulates Mcl-1 stability but also is a potential mechanism for enforcing Mcl-1 dependence.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  Bim phosphorylation; Mcl-1 stability; priming

Mesh:

Substances:

Year:  2018        PMID: 29775995      PMCID: PMC6215700          DOI: 10.1111/febs.14505

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  77 in total

1.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

2.  Procaspase-3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function.

Authors:  Matthew Brentnall; David B Weir; Anthony Rongvaux; Adam I Marcus; Lawrence H Boise
Journal:  J Cell Sci       Date:  2014-03-07       Impact factor: 5.285

3.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

4.  Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function.

Authors:  Xiao-Jun Qi; Gary M Wildey; Philip H Howe
Journal:  J Biol Chem       Date:  2005-11-10       Impact factor: 5.157

5.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

6.  Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1.

Authors:  Shogo Kobayashi; Sun-Hee Lee; Xue W Meng; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Ruth W Craig; Scott H Kaufmann; Gregory J Gores
Journal:  J Biol Chem       Date:  2007-04-25       Impact factor: 5.157

7.  GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.

Authors:  Yu Xue; Jian Ren; Xinjiao Gao; Changjiang Jin; Longping Wen; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2008-05-06       Impact factor: 5.911

8.  Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

Authors:  Andrew W Roberts; Matthew S Davids; John M Pagel; Brad S Kahl; Soham D Puvvada; John F Gerecitano; Thomas J Kipps; Mary Ann Anderson; Jennifer R Brown; Lori Gressick; Shekman Wong; Martin Dunbar; Ming Zhu; Monali B Desai; Elisa Cerri; Sari Heitner Enschede; Rod A Humerickhouse; William G Wierda; John F Seymour
Journal:  N Engl J Med       Date:  2015-12-06       Impact factor: 91.245

9.  Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.

Authors:  Yuzo Kodama; Kojiro Taura; Kouichi Miura; Bernd Schnabl; Yosuke Osawa; David A Brenner
Journal:  Gastroenterology       Date:  2009-01-06       Impact factor: 22.682

10.  Mcl-1 ubiquitination: unique regulation of an essential survival protein.

Authors:  Barbara Mojsa; Iréna Lassot; Solange Desagher
Journal:  Cells       Date:  2014-05-08       Impact factor: 6.600

View more
  7 in total

Review 1.  Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors.

Authors:  Jonas Schwestermann; Andrej Besse; Christoph Driessen; Lenka Besse
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

2.  Phosphoproteomics and Proteomics Reveal Metabolism as a Key Node in LPS-Induced Acute Inflammation in RAW264.7.

Authors:  Yu Luo; Qing Jiang; Zhengwen Zhu; Haseeb Sattar; Jiasi Wu; Wenge Huang; Siyu Su; Yusheng Liang; Ping Wang; Xianli Meng
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 3.  Game of Bones: How Myeloma Manipulates Its Microenvironment.

Authors:  Tyler Moser-Katz; Nisha S Joseph; Madhav V Dhodapkar; Kelvin P Lee; Lawrence H Boise
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

Review 4.  Targeting MCL-1 in cancer: current status and perspectives.

Authors:  Haolan Wang; Ming Guo; Hudie Wei; Yongheng Chen
Journal:  J Hematol Oncol       Date:  2021-04-21       Impact factor: 17.388

5.  Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties.

Authors:  Thomas L Bonneaud; Chloé C Lefebvre; Lisa Nocquet; Agnes Basseville; Julie Roul; Hugo Weber; Mario Campone; Philippe P Juin; Frédérique Souazé
Journal:  Cell Death Dis       Date:  2022-09-14       Impact factor: 9.685

6.  MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.

Authors:  Seiji Arai; Andreas Varkaris; Mannan Nouri; Sen Chen; Lisha Xie; Steven P Balk
Journal:  Elife       Date:  2020-06-02       Impact factor: 8.140

7.  Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.

Authors:  Esperanza M Algarín; Dalia Quwaider; Francisco J Campos-Laborie; Andrea Díaz-Tejedor; Pedro Mogollón; Elena Vuelta; Montserrat Martín-Sánchez; Laura San-Segundo; Lorena González-Méndez; Norma C Gutiérrez; Ramón García-Sanz; Teresa Paíno; Javier De Las Rivas; Enrique M Ocio; Mercedes Garayoa
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.